Doctors hit anticoagulant jackpot

Scientists have designed a synthetic antibody called Ichorcumab, which prevents blood-clotting without causing excessive bleeding.

Doctors discovered the antibody occurring naturally in a patient treated for a head injury. Given the degree of anticoagulation caused by the antibody, the patient could have died, but the bleeding stopped normally.

The synthetic antibody could be administered as a drug to prevent strokes and heart attacks, without causing the excessive bleeding associated with other anticoagulants.

Read more at University of Cambridge

Expert Database

Want to write?

Write an article and join a growing community of more than 61,400 academics and researchers from 2,257 institutions.

Register now